363 Detectability of medication errors in older people prior to potentially preventable admissions Table 2. Continued. Adverse drug event Total MEs Underuse Overuse Misuse ME detectability n (% total) % (n) Drug (n) % (n) Drug (n) % (n) Drug (n) % MEs present during medication review (n) % present MEs detected by STOPP/ START, (n) Non-neuropathic 4 (5.2) 75.0 (3) Analgesics (3) 0.0 (0) N/A 25.0 (1) Analgesics (1) 50.0 (2/4) 0.0 (0/2) Neuropathic 1 (1.3) 100.0 (1) Gabapentin (1) 0.0 (0) N/A 0.0 (0) N/A 0.0 (0/1) N/A Acute renal impairment 4 (5.2) 0.0 (0) N/A 75.0 (3) Diuretics (2) ACE-Ig (1) 25.0 (1) NSAID (1) 50.0 (2/4) 0.0 (0/2) Major constipation or faecal impaction 3 (3.9) 66.7 (2) Laxative (2) 33.3 (1) Opioid (1) 0.0 (0) N/A 33.3 (1/3) 100.0 (1/1) COPD exacerbation 2 (2.6) 50.0 (1) Inhalation corticosteroid (1) 50.0 (1) Opioid (1) 0.0 (0) N/A 50.0 (1/2) 100.0 (1/1) Stroke 2 (2.6) 100.0 (2) Anticoagulationf (1) Antiplatelet therapy (1) 0.0 (0) N/A 0.0 (0) N/A 0.0 (0/2) N/A Dehydration 2 (2.6) 0.0 (0) N/A 50.0 (1) Diuretic (1) 50.0 (1) Diuretic (1) 50.0 (1/2) 100.0 (1/1) Hyponatremia 2 (2.6) 0.0 (0) N/A 100.0 (2) Thiazide (1) Diuretic (1) 0.0 (0) N/A 50.0 (1/2) 100.0 (1/1) Hyperglycaemia 2 (2.6) 100.0 (2) Antihyperglycaemics (2) 0.0 (0) N/A 0.0 (0) N/A 100.0 (2/2) 0.0 (0/2) 4
RkJQdWJsaXNoZXIy MTk4NDMw